Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-13-004521
Filing Date
2013-11-08
Accepted
2013-11-08 11:34:48
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f10q_110813.htm 10-Q 1686002
2 EXHIBIT 31.1 exh_311.htm EX-31.1 13404
3 EXHIBIT 31.2 exh_312.htm EX-31.2 13282
4 EXHIBIT 32.1 exh_321.htm EX-32.1 5384
5 EXHIBIT 32.2 exh_322.htm EX-32.2 5255
  Complete submission text file 0001171843-13-004521.txt   12825860

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT scmp-20130930.xml EX-101.INS 2823183
7 XBRL TAXONOMY EXTENSION SCHEMA scmp-20130930.xsd EX-101.SCH 66438
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scmp-20130930_cal.xml EX-101.CAL 47928
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scmp-20130930_def.xml EX-101.DEF 321450
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE scmp-20130930_lab.xml EX-101.LAB 456452
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scmp-20130930_pre.xml EX-101.PRE 320410
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33609 | Film No.: 131203262
SIC: 2834 Pharmaceutical Preparations